Studies have shown that fingolimod can attenuate the phosphorylation level of molecules in the NF‐κB pathway and decrease the inflammatory cytokines L‐1β and IL‐6 to improve neural defects and reduce neuronal damage in cerebral ischemia/reperfusion rats (Zhang et al., 2022). This evidence concerns the gene NFKB1 and Cerebral ischemia.